SLC35F4

Across TCGA cell cohorts, SLC35F4 mutation is significantly associated with the drug of many other genes, with 14 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible SLC35F4-associated genes across cancer lineages are CCT245467, FY012, and JAK3_7406. Each is linked with SLC35F4 in more than 1 cancer types. Because this analysis shows association rather than direction, both SLC35F4-to-partner and partner-to-SLC35F4 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, CCT245467 grouped by SLC35F4-low versus SLC35F4-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (SLC35F4→partner) and Y-score (partner→SLC35F4) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LARGE_INTESTINE	CCT245467 →	+0.465	+2.807	.029	.045	3	1
LARGE_INTESTINE	FY012 →	+0.409	+2.871	.037	.021	3	1
LARGE_INTESTINE	JAK3_7406 →	+0.494	+2.871	.010	.021	3	1
LARGE_INTESTINE	Pevonedistat →	+0.686	+2.871	.036	.021	3	1
LARGE_INTESTINE	LIMK1 inhibitor BMS4 →	+0.349	+3.008	.041	.016	3	1
LARGE_INTESTINE	FTY-720 →	+0.203	+2.700	.038	.047	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 14 associations by consensus.

CCT245467 by SLC35F4 expression — LARGE_INTESTINE

Explore this box plot interactively →